FIGURE II.
Overall survival after unconditioned HCT for SCID using an unrelated donor comparing the use of pre-HCT serotherapy for GVHD prophylaxis to no serotherapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.